This is the protocol for a review and there is no abstract. The objectives are as follows:, to determine whether the use of oral or sublingual calcium channel blockers reduces mortality, morbidity or blood pressure as compared to oral angiotensin-converting enzyme inhibitors or other drug classes in patients with hypertensive urgencies., to determine whether oral or sublingual calcium channel blockers reduce mortality, morbidity or blood pressure as compared to no treatment., to determine whether oral angiotensin-converting enzyme inhibitors reduce mortality, morbidity or blood pressure as compared to no treatment